175 related articles for article (PubMed ID: 24356457)
1. Occult hepatitis B virus infection in Chinese cryptogenic intrahepatic cholangiocarcinoma patient population.
Li Y; Wang H; Li D; Hu J; Wang H; Zhou D; Li Q; Jiang X; Zhou H; Hu H
J Clin Gastroenterol; 2014; 48(10):878-82. PubMed ID: 24356457
[TBL] [Abstract][Full Text] [Related]
2. Isolated anti-HBc is an independent risk factor for tumor recurrence in intrahepatic cholangiocarcinoma after curative resection.
Xu XB; Hu C; Yang HJ; Zheng SS
Hepatobiliary Pancreat Dis Int; 2022 Oct; 21(5):472-478. PubMed ID: 35948505
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis B virus is associated with the clinical features and survival rate of patients with intrahepatic cholangiocarcinoma.
Tao LY; He XD; Xiu DR
Clin Res Hepatol Gastroenterol; 2016 Dec; 40(6):682-687. PubMed ID: 27282820
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B virus infection increases the risk of cholangiocarcinoma: a meta-analysis and systematic review.
Li M; Li J; Li P; Li H; Su T; Zhu R; Gong J
J Gastroenterol Hepatol; 2012 Oct; 27(10):1561-8. PubMed ID: 22694354
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis B virus infection: a favorable prognostic factor for intrahepatic cholangiocarcinoma after resection.
Zhou HB; Wang H; Li YQ; Li SX; Wang H; Zhou DX; Tu QQ; Wang Q; Zou SS; Wu MC; Hu HP
World J Gastroenterol; 2011 Mar; 17(10):1292-303. PubMed ID: 21455328
[TBL] [Abstract][Full Text] [Related]
6. [Epidemiological and clinical features of occult hepatitis B in HIV infection without antiretroviral treatment].
Zhang RF; Liu L; Zheng YF; Shen YZ; Chen J; Gu SM; Wang JR; Lu HZ
Zhonghua Gan Zang Bing Za Zhi; 2013 Mar; 21(3):189-91. PubMed ID: 23967739
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B virus-related intrahepatic cholangiocarcinoma originates from hepatocytes.
Song Z; Lin S; Wu X; Ren X; Wu Y; Wen H; Qian B; Lin H; Huang Y; Zhao C; Wang N; Huang Y; Peng B; Li X; Peng H; Shen S
Hepatol Int; 2023 Oct; 17(5):1300-1317. PubMed ID: 37368186
[TBL] [Abstract][Full Text] [Related]
8. Level of Hepatitis B (HB) Core Antibody Associates With Seroclearance of HBV DNA and HB Surface Antigen in HB e Antigen-Seronegative Patients.
Hu HH; Liu J; Chang CL; Jen CL; Lee MH; Lu SN; Wang LY; Quan Y; Xia NS; Chen CJ; Chen PJ; Yang HI
Clin Gastroenterol Hepatol; 2019 Jan; 17(1):172-181.e1. PubMed ID: 29753083
[TBL] [Abstract][Full Text] [Related]
9. Prevalence, risk factors and genotypes of hepatitis B infection among HIV-infected patients in the State of MS, Central Brazil.
Freitas SZ; Soares CC; Tanaka TS; Lindenberg AS; Teles SA; Torres MS; Mello FC; Mendes-Corrêa MC; Savassi-Ribas F; Motta-Castro AR
Braz J Infect Dis; 2014; 18(5):473-80. PubMed ID: 24662138
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B virus-associated intrahepatic cholangiocarcinoma and hepatocellular carcinoma may hold common disease process for carcinogenesis.
Zhou H; Wang H; Zhou D; Wang H; Wang Q; Zou S; Tu Q; Wu M; Hu H
Eur J Cancer; 2010 Apr; 46(6):1056-61. PubMed ID: 20202823
[TBL] [Abstract][Full Text] [Related]
11. Occult hepatitis B virus infection in Greek patients with congenital bleeding disorders.
Varaklioti A; Kouramba A; Ioannidou P; Katsarou O
Infect Genet Evol; 2017 Oct; 54():397-401. PubMed ID: 28705716
[TBL] [Abstract][Full Text] [Related]
12. Occult hepatitis B virus infection in Korean patients with isolated anti-HBc.
Kang SY; Kim MH; Lee WI
Arch Virol; 2014 Feb; 159(2):227-33. PubMed ID: 23933720
[TBL] [Abstract][Full Text] [Related]
13. Occult hepatitis B virus infection: implications in transfusion.
Allain JP
Vox Sang; 2004 Feb; 86(2):83-91. PubMed ID: 15023176
[TBL] [Abstract][Full Text] [Related]
14. Quantitation of HBV cccDNA in anti-HBc-positive liver donors by droplet digital PCR: A new tool to detect occult infection.
Caviglia GP; Abate ML; Tandoi F; Ciancio A; Amoroso A; Salizzoni M; Saracco GM; Rizzetto M; Romagnoli R; Smedile A
J Hepatol; 2018 Aug; 69(2):301-307. PubMed ID: 29621551
[TBL] [Abstract][Full Text] [Related]
15. Characterisation and follow-up study of occult hepatitis B virus infection in anti-HBc-positive qualified blood donors in southern China.
Ye X; Li T; Xu X; Du P; Zeng J; Zhu W; Yang B; Li C; Allain JP
Blood Transfus; 2017 Jan; 15(1):6-12. PubMed ID: 27416568
[TBL] [Abstract][Full Text] [Related]
16. Detection of hepatitis B virus DNA in paraffin-embedded intrahepatic and extrahepatic cholangiocarcinoma tissue in the northern Chinese population.
Wu Y; Wang T; Ye S; Zhao R; Bai X; Wu Y; Abe K; Jin X
Hum Pathol; 2012 Jan; 43(1):56-61. PubMed ID: 21777950
[TBL] [Abstract][Full Text] [Related]
17. Occult HBV infection in Morocco: from chronic hepatitis to hepatocellular carcinoma.
Kitab B; Ezzikouri S; Alaoui R; Nadir S; Badre W; Trepo C; Chemin I; Benjelloun S
Liver Int; 2014 Jul; 34(6):e144-50. PubMed ID: 24502524
[TBL] [Abstract][Full Text] [Related]
18. [Atypical serological profiles in hepatitis B infections: investigation of S gene mutations in cases with concurrently positive for HBsAg and anti-HBs].
Aydın N; Kırdar S; Uzun N; Eyigör M; Sayan M
Mikrobiyol Bul; 2016 Oct; 50(4):535-543. PubMed ID: 28124958
[TBL] [Abstract][Full Text] [Related]
19. Molecular and Serological Characterization of Hepatitis B Virus (HBV)-Positive Samples with Very Low or Undetectable Levels of HBV Surface Antigen.
Kuhns MC; Holzmayer V; Anderson M; McNamara AL; Sauleda S; Mbanya D; Duong PT; Dung NTT; Cloherty GA
Viruses; 2021 Oct; 13(10):. PubMed ID: 34696483
[TBL] [Abstract][Full Text] [Related]
20. Viral hepatitis B and C infections increase the risks of intrahepatic and extrahepatic cholangiocarcinoma: Evidence from a systematic review and meta-analysis.
Tan JH; Zhou WY; Zhou L; Cao RC; Zhang GW
Turk J Gastroenterol; 2020 Mar; 31(3):246-256. PubMed ID: 32343237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
